biotechnology
Human microbiome drugs market to be valued at $2.13b by 2031
Human microbiome drugs market to be valued at $2.13b by 2031
By end users, the hospitals & clinics segment held the largest market share in 2024.
Asia-Pacific strengthens biotech edge amidst scaling constraints
Government investment powers rapid biotech growth.
Molecular spectroscopy market to be valued at $6.4b by 2034
Key sectors include pharmaceuticals and biotechnology.
GUTolution's AI-powered tech drives personalised solutions for gut health
The biotech’s algorithm aids in customised recommendations by determining disease risks via one’s gut profile.
German pharmaceutical firm plans new APAC bioprocessing plant in South Korea
Merck will use its Asia Pacific Bioprocessing Center for commercial manufacturing for its biotech and pharmaceutical clients.
From accidental to essential — How PairX Bio revolutionises cancer immunotherapies
The startup focuses its efforts on cancer treatment by targeting shared tumour antigens.
Most Read
1. US tariffs trigger 123% Singapore pharma output surge 2. Australia commits $80.33m to 60 medical research trials 3. VPD outbreak risks loom as coverage falls below 85%: report 4. AI, cloud to drive $10.2b medical imaging market shift by 2033 5. Malaysia’s KMC to launch AI‑powered MRI system to boost diagnostic capacityResource Center
Read Here
Advertise
Sign Up
Events
Event News
Healthcare Asia Awards 2025 Winner: Lee Ligang Zhang of iKang Healthcare Group
Lee Ligang Zhang of iKang Healthcare Group highlights how AI and precision diagnosis are transforming healthcare delivery today.
